The New York Times

Her Sudden Back Pain Was Unbearable. What Could Ease It?

For a doctor and a mother of four, there was almost no relief to be found. By Lisa Sanders, M.D. The 42-year-old woman walked with her twin sons and older daughter through the nearly empty walkways at ...
Times-Standard

Ask the Doctors | Raynaud’s syndrome typically affects the fingers

Dear Doctors: I have problems with circulation in my hands. I came across information about something called Raynaud’s phenomenon and want to know if that is happening to me. Where does one go to get ...
Cincinnati

Addressing Pain in the Brain for Restless Legs Syndrome

Marc Orlando, M.D., is an interventional pain management specialist at Mayfield Brain & Spine, an internationally recognized leader in neurological surgery known for patient-centered care. He’s ...
The Bluffton Icon

Weekend Doctor: Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) is a chronic neurological condition that causes severe pain in a limb. The pain is disproportionate to the injury or trauma that caused it. This affects roughly ...
Monthly Prescribing Reference

Efficacy and Safety of Bisphosphonates Explored in Complex Regional Pain Syndrome

Eleven trials with 754 participants, assessing alendronate, clodronate, neridronate, pamidronate, and zoledronate, were included. HealthDay News — Bisphosphonates may reduce complex regional pain ...
Hosted on MSN

Efficacy and safety of bisphosphonates explored in complex regional pain syndrome

THURSDAY, Dec. 18, 2025 (HealthDay News) -- Bisphosphonates may reduce complex regional pain syndrome (CRPS) pain intensity in the short term, according to a study published online Dec. 16 in Annals ...
BioSpace

Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1

Neridronate granted FDA Breakthrough Therapy, Fast-Track, and Orphan Drug designations; pivotal Phase 3 trial planned to start in the first quarter of 2026 Jay Hagan joins as Chief Executive Officer ...
FierceBiotech

Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug

Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech. The new firm, Ambros Therapeutics, debuted Tuesday with a $125 million series A and plans to develop a ...
MarketWatch

Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1

The MarketWatch News Department was not involved in the creation of this content. -- Neridronate granted FDA Breakthrough Therapy, Fast-Track, and Orphan Drug designations; pivotal Phase 3 trial ...
KRQE Blogs

Centennial Spine and Pain offers treatment for Complex Regional Pain Syndrome

Dr. John Watkins from Centennial Spine and Pain joins New Mexico Living to talk about Complex Regional Pain Syndrome. He speaks on what it is and how it can be remedied. Dr. Watkins says it is a ...
Frontiers

Nociception level index as a tool of measuring pain objectively in patients with complex regional pain syndrome: a feasibility study

Introduction: This study evaluates the feasibility of using the Nociception Level Index (NOL) as an objective tool for assessing pain in awake patients with Complex Regional Pain Syndrome (CRPS).